As of 2025-10-27, the Relative Valuation of Trxade Group Inc (MEDS) is 15.02 USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.59 USD, the upside of Trxade Group Inc based on Relative Valuation is 97.9%.
The range of the Relative Valuation is 11.68 - 19.28 USD.
| Range | Selected | |
| Trailing P/E multiples | 29.2x - 36.7x | 33.0x |
| Forward P/E multiples | 22.2x - 26.1x | 24.2x |
| Fair Price | 11.68 - 19.28 | 15.02 |
| Upside | 53.8% - 154.1% | 97.9% |
| Date | P/E |